• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

技术洞察:体外光化学疗法治疗移植物抗宿主病——我们能否在不进行全身性免疫抑制的情况下实现选择性免疫控制?

Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?

作者信息

Marshall Scott R

机构信息

Department of Haematological Sciences, School of Clinical and Laboratory Sciences, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.

出版信息

Nat Clin Pract Oncol. 2006 Jun;3(6):302-14. doi: 10.1038/ncponc0511.

DOI:10.1038/ncponc0511
PMID:16757968
Abstract

Hematopoietic stem-cell transplantation remains an important curative therapy for many conditions and its use is increasing annually. Graft-versus-host disease (GvHD) is the major cause of mortality and suffering following allogeneic hematopoietic stem-cell transplantation. Conventional treatments are associated with multiple side effects and are often ineffective. New therapeutic approaches for the control of GvHD are desperately required. Extracorporeal photochemotherapy (ECP) was developed in the 1970s for the treatment of cutaneous T-cell lymphoma and was approved by the FDA as the first selective immunotherapy for a cancer. ECP has also proved an effective therapy for immune-related conditions, particularly GvHD, even in patients refractory to conventional therapies. The treatment involves the mechanical separation of circulating white cells, which are exposed to psoralen and UVA light and then returned to the patient. ECP is extremely well tolerated with minimal side effects and is not associated with the increased rates of infection or relapse of malignant disease typical of conventional immunosuppressive agents. Thus, ECP appears to offer selective immune modulation without generalized immunosuppression, but its mechanism of action remains poorly understood. This review discusses the development of ECP, its use in the treatment of GvHD, as well as current theories of its mechanism of action.

摘要

造血干细胞移植仍然是许多疾病的重要治愈性疗法,且其应用每年都在增加。移植物抗宿主病(GvHD)是异基因造血干细胞移植后导致死亡和痛苦的主要原因。传统治疗伴有多种副作用且往往无效。迫切需要控制GvHD的新治疗方法。体外光化学疗法(ECP)于20世纪70年代开发用于治疗皮肤T细胞淋巴瘤,并被美国食品药品监督管理局(FDA)批准为第一种用于癌症的选择性免疫疗法。ECP也已被证明是治疗免疫相关疾病,特别是GvHD的有效疗法,即使在对传统疗法难治的患者中也是如此。该治疗包括机械分离循环白细胞,将其暴露于补骨脂素和紫外线A光下,然后再回输给患者。ECP耐受性极佳,副作用极小,且与传统免疫抑制剂典型的感染率增加或恶性疾病复发无关。因此,ECP似乎能提供选择性免疫调节而无全身性免疫抑制,但其作用机制仍知之甚少。本综述讨论了ECP的发展、其在治疗GvHD中的应用以及当前关于其作用机制的理论。

相似文献

1
Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?技术洞察:体外光化学疗法治疗移植物抗宿主病——我们能否在不进行全身性免疫抑制的情况下实现选择性免疫控制?
Nat Clin Pract Oncol. 2006 Jun;3(6):302-14. doi: 10.1038/ncponc0511.
2
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
3
Extracorporeal photopheresis in chronic graft-versus-host disease.体外光分离置换法治疗慢性移植物抗宿主病
Bone Marrow Transplant. 2002 May;29(9):719-25. doi: 10.1038/sj.bmt.1703529.
4
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.体外光化学疗法用于异基因干细胞移植后类固醇难治性或类固醇依赖性皮肤慢性移植物抗宿主病的治疗:可行性及结果
Bone Marrow Transplant. 2003 Mar;31(6):459-65. doi: 10.1038/sj.bmt.1703871.
5
Treatment of graft versus host disease (GVHD) by photopheresis?光分离置换法治疗移植物抗宿主病(GVHD)?
Transfus Sci. 1996 Dec;17(4):527-36.
6
Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.体外光化学疗法治疗慢性移植物抗宿主病的作用机制
Br J Dermatol. 2004 Jun;150(6):1055-60. doi: 10.1111/j.1365-2133.2004.05918.x.
7
Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.体外光化学疗法可使慢性移植物抗宿主病中的某些淋巴细胞亚群(包括调节性T细胞)恢复正常。
Ther Apher Dial. 2008 Aug;12(4):311-8. doi: 10.1111/j.1744-9987.2008.00593.x.
8
Extracorporeal photopheresis in children with graft-versus-host disease.体外光化学疗法治疗儿童移植物抗宿主病
J Clin Apher. 2006 Apr;21(1):60-4. doi: 10.1002/jca.20087.
9
Extracorporeal photopheresis: from solid organs to face transplantation.体外光化学疗法:从实体器官移植到面部移植。
Transpl Immunol. 2009 Jul;21(3):117-28. doi: 10.1016/j.trim.2009.04.005. Epub 2009 May 3.
10
Extracorporeal photochemotherapy.体外光化学疗法
J Dermatol Sci. 2009 Jun;54(3):150-6. doi: 10.1016/j.jdermsci.2009.03.002. Epub 2009 Apr 14.

引用本文的文献

1
Extracorporeal Photopheresis in Pediatric and Adult Patients with Graft-Versus-Host Disease.体外光化学疗法治疗儿童和成人移植物抗宿主病
J Clin Med. 2024 Sep 1;13(17):5192. doi: 10.3390/jcm13175192.
2
Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy.体外光分离术作为 CAR T 细胞治疗后移植物抗宿主病的一种有前途的治疗策略。
Blood Adv. 2024 Jun 11;8(11):2675-2690. doi: 10.1182/bloodadvances.2023012463.
3
Extracorporeal Photopheresis in Graft-versus-Host Disease.
体外光化学疗法治疗移植物抗宿主病
Transfus Med Hemother. 2020 Jun;47(3):214-225. doi: 10.1159/000508169. Epub 2020 May 19.
4
Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response.体外光化学疗法诱导的人凋亡细胞可调节同种异体免疫反应。
Front Immunol. 2019 Dec 18;10:2908. doi: 10.3389/fimmu.2019.02908. eCollection 2019.
5
Extracorporeal photopheresis: Review of technical aspects.体外光化学疗法:技术层面综述
Asian J Transfus Sci. 2017 Jul-Dec;11(2):81-86. doi: 10.4103/ajts.AJTS_87_16.
6
effects of different 8-methoxypsoralen treatment protocols for extracorporeal photopheresis on mononuclear cells.不同8-甲氧基补骨脂素治疗方案用于体外光化学疗法对单核细胞的影响
Cent Eur J Immunol. 2017;42(1):1-9. doi: 10.5114/ceji.2017.67312. Epub 2017 May 8.
7
The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.体外光化学疗法在皮肤T细胞淋巴瘤、移植物抗宿主病及器官移植排斥反应管理中的作用:英国光化学疗法协会共识声明更新
Br J Haematol. 2017 Apr;177(2):287-310. doi: 10.1111/bjh.14537. Epub 2017 Feb 21.
8
Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation.异基因造血干细胞移植后急性移植物抗宿主病的体外光化学疗法治疗
F1000Res. 2016 Jun 27;5. doi: 10.12688/f1000research.8118.1. eCollection 2016.
9
Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.体外光化学疗法对中性粒细胞的调节作用及凋亡在慢性移植物抗宿主病治疗中的研究
PLoS One. 2015 Aug 4;10(8):e0134518. doi: 10.1371/journal.pone.0134518. eCollection 2015.
10
Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma.体外光化学疗法:耐受性或免疫原性细胞死亡?超越当前的教条。
Front Immunol. 2015 Jul 7;6:349. doi: 10.3389/fimmu.2015.00349. eCollection 2015.